Multimorbidity and SARS-CoV-2-Related Outcomes: Analysis of a Cohort of Italian Patients.
Alberto CatalanoLucia DanseroWinston GilcreaseAlessandra MacciottaCarlo SaugoLuca ManfrediRoberto GnaviElena StrippoliNicolás ZengariniValeria CaramelloGiuseppe CostaCarlotta SacerdoteFulvio RicceriPublished in: JMIR public health and surveillance (2023)
Our study shows that patients with multimorbidity, although swabbed more frequently, are less likely to get infected with SARS-CoV-2, probably due to greater attention on protective methods. Moreover, a history of respiratory diseases is a risk factor for a worse prognosis of COVID-19. Nonetheless, whatever comorbidities affect the patients, a strong dose-response effect was observed between an increased CCI score and COVID-19 hospitalization, ICU admission, and death. These results are important in terms of public health because they help in identifying a group of subjects who are more prone to worse SARS-CoV-2 outcomes. This information is important for promoting targeted prevention and developing policies for the prioritization of public health interventions.
Keyphrases
- sars cov
- public health
- end stage renal disease
- respiratory syndrome coronavirus
- newly diagnosed
- coronavirus disease
- ejection fraction
- chronic kidney disease
- prognostic factors
- emergency department
- peritoneal dialysis
- intensive care unit
- adipose tissue
- healthcare
- neuropathic pain
- physical activity
- working memory
- metabolic syndrome
- skeletal muscle
- patient reported
- insulin resistance
- global health
- respiratory tract
- glycemic control